CHI3L1 and Hepatic fibrosis: These findings suggest that while serum CHI3L1 can serve as a valuable indicator for assessing liver fibrosis in AILDs within clinical settings, it is important to avoid applying a universal diagnostic threshold, particularly when patients exhibit active inflammation, as CHI3L1 values tend to be higher in such cases.